GERON CORP Deferred Tax Assets, Goodwill and Intangible Assets
GERON CORP (GERN) had Deferred Tax Assets, Goodwill and Intangible Assets of $6.30 million as of 2013-12-31, per its 10-K filed 2015-03-11.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2015-03-11
- 2013-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $6.30M.
- 2012-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $20.00M.
- 2011-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $22.20M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2013-12-31 | $6.30M 10-K · filed 2015-03-11 |
| 2012-12-31 | $20.00M 10-K · filed 2014-03-17 |
| 2011-12-31 | $22.20M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |